Achieve Life Sciences (ACHV) Insider & Congress Trades

Smart money at a glance

Filings to Oct 27, 2026

Net selling: insiders sold $175K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: -$175K netNet selling
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 2 added, 0 cutMore adding
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about ACHV filings

Are insiders buying or selling Achieve Life Sciences Inc (ACHV) stock?

Net selling: insiders sold $175K and bought $0 of ACHV stock on the open market in the 90 days to Oct 27, 2026, according to SEC Form 4 filings. The largest was Stewart, Richard Alistair (Director), who sold $175K. The latest filing was on Aug 21, 2026.

Which members of Congress have traded ACHV recently?

None. No member of Congress disclosed a ACHV trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ACHV smart-money data?

This summary uses filings available on Oct 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on ACHV

Lean long1 source:
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Richard Alistair Stewart, sold $175K, open market, filed Aug 21
Lean short · thin1 sale · $175K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
- BlackRock, added +$33.1M, holdings at Jun 30
- State Street, added +$18.5M, holdings at Jun 30
Lean long · thin2 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ACHV filings

Are insiders buying or selling Achieve Life Sciences Inc (ACHV) stock?

Which members of Congress have traded ACHV recently?

None. No member of Congress disclosed a ACHV trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ACHV smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$51.6M

Buys/Adds (2)

BR
BlackRock
Q2 2026 13F
$33.1M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
SS
State Street
Q2 2026 13F
$18.5M
added

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 6, 2026

Earnings came in 55.6% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 6, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.28-55.56% miss

-$0.18 expected

Revenue

$0.00

SEC filing · No operating revenue

Next report

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Period ending	Reported	EPS / estimate	EPS surprise	Revenue / income	Surprise
Jun 30, 2026	Aug 6, 2026	-$0.28 / -$0.18Alpha Vantage	-55.56% miss	$0.00 No estimateSEC filing · No operating revenue	Unavailable
Mar 31, 2026	May 12, 2026	-$0.19 / -$0.30Alpha Vantage	+36.67% beat	Unavailable	Unavailable
Dec 31, 2025	Mar 24, 2026	-$0.28 / -$0.28Alpha Vantage	-1.05% miss	Unavailable	Unavailable
Sep 30, 2025	Nov 6, 2025	-$0.28 / -$0.26Alpha Vantage	-7.69% miss	Unavailable	Unavailable
Jun 30, 2025	Aug 7, 2025	-$0.37 / -$0.37Alpha Vantage	+0.00% in line	Unavailable	Unavailable
Mar 31, 2025	May 13, 2025	-$0.37 / -$0.37Alpha Vantage	+0.00% in line	Unavailable	Unavailable
Dec 31, 2024	Mar 11, 2025	-$0.36 / -$0.36Alpha Vantage	+0.00% in line	Unavailable	Unavailable
Sep 30, 2024	Nov 7, 2024	-$0.36 / -$0.29Alpha Vantage	-24.14% miss	Unavailable	Unavailable

EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.

Open: $6.48
52-wk high: $8.64
High: $6.61
52-wk low: $2.62
Low: $6.36
Prev close: $6.50
Mkt cap: $669.1M
ROE: -845.0%
Fwd P/E: 35.3x
Beta: 2.31
P/S: 5.1x
P/B: 64.0x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 35.34
Market cap: $669M

Valuation

P/S5.09
P/B64.03

Quality

Operating margin0.0%
ROE-845.0%
ROA-29.2%

Growth

Beta2.31

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

25 / 100

RSI 14

36balanced

20D volatility

56%annualized

52-week range

$6.49

$2.62$8.64

20D support

$6.22recent floor

20D resistance

$8.28recent ceiling

Returns

5D +1.7%20D -13.9%60D +3.0%

Price vs moving averages

SMA20 -8.1%SMA50 -14.0%SMA200 +15.7%

Volume pace

0.85xvs prior 20D

Period ending

Reported

EPS / estimate

EPS surprise

Revenue / income

Surprise

Jun 30, 2026

Aug 6, 2026

-$0.28 / -$0.18Alpha Vantage

-55.56% miss

$0.00 No estimateSEC filing · No operating revenue

Unavailable

Mar 31, 2026

May 12, 2026

-$0.19 / -$0.30Alpha Vantage

+36.67% beat

Unavailable

Dec 31, 2025

Mar 24, 2026

-$0.28 / -$0.28Alpha Vantage

-1.05% miss

Unavailable

Sep 30, 2025

Nov 6, 2025

-$0.28 / -$0.26Alpha Vantage

-7.69% miss

Unavailable

Jun 30, 2025

Aug 7, 2025

-$0.37 / -$0.37Alpha Vantage

+0.00% in line

Unavailable

Mar 31, 2025

May 13, 2025

-$0.37 / -$0.37Alpha Vantage

+0.00% in line

Unavailable

Dec 31, 2024

Mar 11, 2025

-$0.36 / -$0.36Alpha Vantage

+0.00% in line

Unavailable

Sep 30, 2024

Nov 7, 2024

-$0.36 / -$0.29Alpha Vantage

-24.14% miss

Unavailable

Achieve Life Sciences Inc

Smart money at a glance

What do analysts expect?

Questions about ACHV filings

Smart money on ACHV

Questions about ACHV filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 55.6% below what analysts expected.

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Is the business strong?

Price structure

Achieve Life Sciences Inc

Smart money at a glance

What do analysts expect?

Questions about ACHV filings

Smart money on ACHV

Questions about ACHV filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 55.6% below what analysts expected.

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Is the business strong?

Price structure

Achieve Life Sciences Inc

Overview

Questions about ACHV filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Achieve Life Sciences Inc

Overview

Questions about ACHV filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals